#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Breast cancer metastatic Immune-mediated myositis Metachromatic leukodystrophy Squamous cell carcinoma of the hypopharynx Liver transplant rejection Glioblastoma multiforme Polyneuropathy Haemophilia B without inhibitors T-cell lymphoma Squamous cell carcinoma of the oral cavity Mantle cell lymphoma stage IV MELAS syndrome Turner's syndrome Biliary cancer metastatic Lennox-Gastaut syndrome More trials…

    Learn about Rare Diseases

    Hereditary optic atrophy Mucous membrane pemphigoid – Diagnostics Mastocytosis Pulmonary sarcoidosis – Treatment Progressive supranuclear palsy Congenital nephrogenic diabetes insipidus – Life with Disease Tuberous sclerosis complex – Diagnostics Bronchopulmonary dysplasia – Treatment Medulloblastoma recurrent – Treatment Pelizaeus-Merzbacher disease – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Topotecan Hydrochloride ALE1 Adagrasib Sotalol Hydrochloride Umeclidinium Ciprofloxacin INSULIN DETEMIR Povetacicept Treprostinil Sodium SKB410 Isoniazid Estradiol Valerate Corylus Avellana L. Sodium ANTIMETABOLITES INSULIN DEGLUDEC Cedazuridine Mirikizumab Db-Oto-3 Ziftomenib More therapies…

    Learn about Your Condition

    Genital herpes Myelodysplastic syndrome CADASIL Pituitary tumour benign Cystic fibrosis Hidradenitis Chronic kidney disease Antithrombin III deficiency Laparoscopic surgery Respiratory tract infection Partial seizures Ventricular tachycardia Colorectal adenoma Petit mal epilepsy Behavioural addiction More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

United Kingdom

  • Study of drug combination therapy for high-risk medulloblastoma in patients over 3 years of age: carboplatin, cisplatin, cyclophosphamide, lomustine, temozolomide, thiotepa, vincristine

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Lomustine
    • Temozolomide
    • Carboplatin
    Austria Belgium Czechia Denmark Finland Germany +4

  • Study of Atropine Sulfate eye drops (0.

    Not recruiting

    3 1
    Investigated Drugs:
    • Atropine Sulfate
    Hungary Ireland Poland Slovakia Spain

Find Clinical Trials in Your Selected Region and City

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Thiotepa Vincristine Sulfate Atropine Sulfate Lomustine Temozolomide Carboplatin Cisplatin Cyclophosphamide Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Medulloblastoma Myopia

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!